Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells

Oncogene

Volumn 15, Issue 17, 1997, Pages 2069-2075

  Xie, Shanhai ^a   Price, Janet E ^a   Luca, Mario ^a   Jean, Didier ^a   Ronai, Zeèv ^b   Bar Eli, Menashe ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Collagenase; CREB; Dominant negtive; Malignant melanoma; Metastatsis

Indexed keywords

CELL ADHESION MOLECULE; CHLORAMPHENICOL ACETYLTRANSFERASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GELATINASE A; MATRIGEL; MESSENGER RNA; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MELANOMA; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SKIN CARCINOGENESIS; TRANSCRIPTION REGULATION;

ANIMALIA; EUKARYOTA; MUS MUSCULUS;

EID: 0030726539     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201358     Document Type: Article

References (46)

1. Abdel-Malek Abdel-Hafiz H, Chen CY, Marcell T, Kroll DJ and Hoeffler JP. (1993). Oncogene, 8, 1161-1174.
2. Aslakson CJ and Miller FR (1992). Cancer Res., 52, 1399-1405.
3. Ballin M, Gomez DE, Sinha CC and Thorgeirsson UP. (1988). Biochem. Biophys. Res. Commun., 154, 832-838.
4. Bernstein LR and Liotta LA (1994). Curr. Opin. Oncol., 6, 106-113.
5. Bohm M, Moellmann G, Cheng E, Alvarez-Franco M, Wagner S, Sassone-Corsi P and Halaban R. (1995). Cell Growth & Different., 6, 291-302.
6. Borrelli E, Montmayeur JP, Foulkes NS and Sassone-Corsi P. (1992). Crit. Rev. Oncog., 3, 321-338.
7. Ellenberger TE, Brandl CJ, Struhl K and Harrison SC. (1992). Cell, 71, 1223-1237.
8. Fidler IJ. (1990). Cancer Res., 50, 6130-6138.
9. Gorman CM, Moffat LF and Howard BH. (1982). Mol. Cell Biol., 2, 1044-1051.
10. Hai T and Curran T. (199). Proc. Natl. Acad. Sci. USA, 88, 3720-3724.
11. Halaban R. (1993). Semin. Cancer Biol., 4, 171-181.
12. Halaban R, Ghosh S and Baird A. (1987). In Vitro Cell Dev. Biol., 23, 47-52.
13. Halaban R, Pomerantz SH, Marshall S, Lambert DT and Lerner AB. (1983). J. Cell Biol., 97, 480-488.
14. Halaban R, Pomerantz SH, Marshall S and Lerner AB. (1984). Arch Biochem. Biophys., 230, 383-387
15. Hudson JM, Frade R and Bar-Eli M. (1995) DNA and Cell Biol., 14, 759-766.
16. Huhtala P, Chow LT and Tryggvason K. (1990). J. Biol. Chem., 265, 11077-11082.
17. Huang S, Luca M, Gutman M, McConkey DJ, Langley KE, Lyman SD and Bar-Eli M. (1996a). Oncogene, 13, 2339-2347.
18. Huang S, Xie K, Bucana CD, Ullrich SE and Bar-Eli M. (1996b). Clin. Cancer Res., 2, 1969-1979.
19. Hunter T and Karin M. (1992). Cell, 70, 375-387.
20. Kwok RPS, Lundblad JR, Chrivia JC, Richards JP, Bachinger HP, Brennan RG, Roberts SGE, Green MR and Goodman RH. (1994). Nature, 37, 223-226.
21. Lanschultz WH, Johnson PF and McKnight SL. (1988). Science, 240, 1759-1764.
22. Lehmann JM, Riethmuller G and Johnson JP. (1989). Proc. Natl. Acad. Sci. USA, 89, 9891-9895.
23. Lester BR and McCarthy JB. (1992). Curr. Opin. Oncol., 6, 106-113.
24. Li L, Price JE, Fan D, Zhang RD, Bucana CD and Fidler IJ. (1989). J. Natl. Cancer Inst., 81, 1406-1412.
25. Lu C and Kerbel RS. (1994). Curr. Opin. Oncol., 6, 212-220.
26. Luca M. Hunt B, Bucana CD, Johnson JP, Fidler IJ and Bar-Eli M. (1993). Melanoma Res., 3, 35-41.
27. Luca M. Xie S, Gutman M, Huang S and Bar-Eli M. (1995). Oncogene, 11, 1399-1402.
28. Mohler JL, Levy F and Sharief Y. (1991). Cancer Res., 50, 6580-6585.
29. Montminy MR and Bilezikjian LM (1987). Nature, 328, 175-178.
30. Patrin AW, Schoeniger JS, Mohler JL and Coffey DS. (1991). Proc. Natl. Acad. Sci. USA, 86, 1254-1258.
31. Radinsky R, Fidler IJ, Price JE, Esumi N, Tsan R, Petty CM, Bucana CD and Bar-Eli M. (1994). Oncogene, 9, 1977-1983.
32. Ray JM and Stetler-Stevenson WG. (1995). EMBO J., 14, 908-917.
33. Roesler WJ, Vandenbark GR and Hanson RW. (1988). J. Biol. Chem., 263, 9063-9066.
34. Rutberg SE, Goldstein IM, Yang YM, Stackpole CE and Ronai Z. (1994). Mol. Carcinogen., 10, 82-87.
35. Sers C, Kirsch K, Rothbacher U, Reithmuller G and Johnson JP. (1993). Proc. Natl. Acad. Sci. USA, 90, 8514-8518.
36. Singh RK, Gutman M, Reich R and Bar-Eli M. (1995). Cancer Res., 55, 3669-3674.
37. Van leeuwen RL, Dekker SK, Arbiser JL, Vermeer BJ, Bruijn JA and Byers HR. (1994). Intl. J. Cancer, 57, 894-900.
38. Vinson CR, Sigler P and McKnight SL. (1989). Science, 246, 911-922.
39. Walton KM, Rehfuss RP. Chrivia JC, Lochner JE and Goodman RH. (1992). Mol. Endo., 6, 647-655.
40. Wanda T, Watanabe H, Usuda Y and Handa H. (1991). J. Virol., 65, 557-564.
41. Welch DR, Bisi JE, Miller BE, Conaway D, Seftor EA, Yohem KH, Gilmore LB, Seftor RE, Nakajima M and Hendrix MJ. (1991). Int. J. Cancer, 47, 227-237.
42. Woloshin PI, Waton KM, Rehfuss RP, Goodman RH and Cone RD. (1992). Mol. Endo., 6, 1725-1733.
43. Xie S, Luca M, Huang S, Gutman M, Reich R, Johnson JP and Bar-Eli M. (1997). Cancer Res., 57, 2295-2303.
44. Xing J, Ginty DD and Greenberg ME. (1996). Science, 273, 959-963.
45. Yamamoto KK, Gonzalez GA, Biggs WH III and Montminy MR. (1988). Nature, 334, 494-498.
46. Yang YM, Dolan LR and Roni Z. (1996). Oncogene, 12, 2223-2233.